Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 54% ± 20% | |
brain | 19 studies | 39% ± 15% | |
peripheral blood | 18 studies | 52% ± 13% | |
intestine | 12 studies | 44% ± 23% | |
eye | 11 studies | 43% ± 18% | |
kidney | 9 studies | 53% ± 14% | |
liver | 7 studies | 42% ± 22% | |
lymph node | 6 studies | 45% ± 16% | |
heart | 6 studies | 29% ± 12% | |
pancreas | 5 studies | 66% ± 27% | |
bone marrow | 5 studies | 41% ± 20% | |
uterus | 5 studies | 63% ± 20% | |
adipose | 5 studies | 27% ± 11% | |
prostate | 5 studies | 46% ± 24% | |
placenta | 4 studies | 69% ± 28% | |
breast | 4 studies | 56% ± 5% | |
adrenal gland | 3 studies | 38% ± 7% | |
esophagus | 3 studies | 48% ± 33% | |
skin | 3 studies | 52% ± 12% | |
thymus | 3 studies | 67% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 14703.67 | 1445 / 1445 | 100% | 82.49 | 183 / 183 |
lung | 100% | 15750.43 | 578 / 578 | 100% | 107.82 | 1155 / 1155 |
ovary | 100% | 18469.94 | 180 / 180 | 100% | 87.39 | 430 / 430 |
brain | 100% | 18365.00 | 2640 / 2642 | 100% | 153.72 | 705 / 705 |
breast | 100% | 17231.44 | 459 / 459 | 100% | 122.65 | 1117 / 1118 |
prostate | 100% | 13932.66 | 245 / 245 | 100% | 96.72 | 501 / 502 |
uterus | 100% | 18200.32 | 170 / 170 | 100% | 116.96 | 458 / 459 |
thymus | 100% | 14927.96 | 653 / 653 | 100% | 134.42 | 603 / 605 |
kidney | 100% | 14596.99 | 89 / 89 | 99% | 96.54 | 896 / 901 |
bladder | 100% | 17314.71 | 21 / 21 | 99% | 91.29 | 501 / 504 |
skin | 100% | 13700.37 | 1806 / 1809 | 99% | 122.70 | 467 / 472 |
adrenal gland | 100% | 16941.36 | 258 / 258 | 99% | 125.76 | 227 / 230 |
liver | 99% | 6940.90 | 224 / 226 | 100% | 58.17 | 404 / 406 |
stomach | 100% | 11485.42 | 359 / 359 | 99% | 71.01 | 282 / 286 |
intestine | 100% | 16601.08 | 966 / 966 | 98% | 79.21 | 519 / 527 |
pancreas | 95% | 5312.67 | 311 / 328 | 100% | 113.19 | 178 / 178 |
adipose | 100% | 18024.90 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 23755.67 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 95.66 | 29 / 29 |
muscle | 100% | 16259.94 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 13225.12 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 94.81 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 34.77 | 1 / 1 |
heart | 99% | 13494.34 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 85.35 | 79 / 80 |
peripheral blood | 90% | 9992.63 | 836 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_2000779 | Biological process | regulation of double-strand break repair |
GO_0051726 | Biological process | regulation of cell cycle |
GO_1905168 | Biological process | positive regulation of double-strand break repair via homologous recombination |
GO_0016607 | Cellular component | nuclear speck |
GO_0070822 | Cellular component | Sin3-type complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000786 | Cellular component | nucleosome |
GO_0035267 | Cellular component | NuA4 histone acetyltransferase complex |
GO_0005515 | Molecular function | protein binding |
Gene name | MORF4L1 |
Protein name | MORF4L1 protein Mortality factor 4-like protein 1 (MORF-related gene 15 protein) (MRG15) (Protein MSL3-1) (Transcription factor-like protein MRG15) Mortality factor 4 like 1 (cDNA FLJ38504 fis, clone HCHON2000156, highly similar to Mortality factor 4-like protein 1) Mortality factor 4 like 1 |
Synonyms | HSPC061 MRG15 PP368 FWP006 HSPC008 |
Description | FUNCTION: Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. NuA4 may also play a direct role in DNA repair when directly recruited to sites of DNA damage. As part of the SIN3B complex represses transcription and counteracts the histone acetyltransferase activity of EP300 through the recognition H3K27ac marks by PHF12 and the activity of the histone deacetylase HDAC2 . SIN3B complex is recruited downstream of the constitutively active genes transcriptional start sites through interaction with histones and mitigates histone acetylation and RNA polymerase II progression within transcribed regions contributing to the regulation of transcription . Required for homologous recombination repair (HRR) and resistance to mitomycin C (MMC). Involved in the localization of PALB2, BRCA2 and RAD51, but not BRCA1, to DNA-damage foci. . |
Accessions | ENST00000426013.7 [Q9UBU8-2] ENST00000558502.5 [Q9UBU8-3] ENST00000558830.5 H0YNI8 H0YNX3 Q9UBU8 ENST00000559751.1 H0YLV1 Q0VAE4 ENST00000331268.9 [Q9UBU8-1] H0YNE0 ENST00000379535.8 B3KTM8 H0YMT8 A5D8W6 ENST00000559244.5 ENST00000559690.5 ENST00000559158.5 ENST00000560422.5 ENST00000559345.5 [Q9UBU8-3] ENST00000558746.5 H0YM21 H0YLJ3 ENST00000559930.5 H0YMJ0 |